These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37909291)

  • 1. Adapted risk stratification and intensive chemotherapy abrogate the poor prognosis of pediatric B acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21): a National cohort analysis.
    Trinquand A; Betts DR; Harte S; Sills A; Rooney S; Barrett N; Storey L; Malone A; O'Marcaigh A; Smith OP
    Leuk Lymphoma; 2024 Feb; 65(2):279-282. PubMed ID: 37909291
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
    Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
    J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is intrachromosomal amplification of chromosome 21 (iAMP21) always intrachromosomal?
    Tsuchiya KD; Davis B; Gardner RA
    Cancer Genet; 2017 Dec; 218-219():10-14. PubMed ID: 29153092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-Cell Acute Lymphoblastic Leukemia with iAMP21 in a Patient with Constitutional Ring Chromosome 21.
    Baloda V; Aggarwal N; Rosado FG; Mackey S; Felker J; Yatsenko SA
    Cytogenet Genome Res; 2022; 162(5):231-236. PubMed ID: 36502796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Spotlight on iAMP21 acute lymphoblastic leukemia (ALL), a high-risk pediatric disease.
    Harrison CJ
    Blood; 2015 Feb; 125(9):1383-6. PubMed ID: 25608562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and genetic evaluation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21) in adult patients.
    Zak T; Gao J; Behdad A; Mehta J; Altman JK; Ji P; Lu X; Sukhanova M
    Leuk Lymphoma; 2022 Dec; 63(13):3200-3207. PubMed ID: 35995457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH2B3 aberrations enriched in iAMP21 B lymphoblastic leukemia.
    Baughn LB; Meredith MM; Oseth L; Smolarek TA; Hirsch B
    Cancer Genet; 2018 Oct; 226-227():30-35. PubMed ID: 30005852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic Variation of B-Lymphoblastic Leukemia With Intrachromosomal Amplification of Chromosome 21 (iAMP21): A Multi-Institutional Series Review.
    Johnson RC; Weinberg OK; Cascio MJ; Dahl GV; Mitton BA; Silverman LB; Cherry AM; Arber DA; Ohgami RS
    Am J Clin Pathol; 2015 Jul; 144(1):103-12. PubMed ID: 26071468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia.
    Rand V; Parker H; Russell LJ; Schwab C; Ensor H; Irving J; Jones L; Masic D; Minto L; Morrison H; Ryan S; Robinson H; Sinclair P; Moorman AV; Strefford JC; Harrison CJ
    Blood; 2011 Jun; 117(25):6848-55. PubMed ID: 21527530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
    Moorman AV; Robinson H; Schwab C; Richards SM; Hancock J; Mitchell CD; Goulden N; Vora A; Harrison CJ
    J Clin Oncol; 2013 Sep; 31(27):3389-96. PubMed ID: 23940220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
    Attarbaschi A; Panzer-Grümayer R; Mann G; Möricke A; König M; Mecklenbräuker A; Teigler-Schlegel A; Bradtke J; Harbott J; Göhring G; Stanulla M; Schrappe M; Zimmermann M; Haas OA;
    Klin Padiatr; 2014 Nov; 226(6-7):338-43. PubMed ID: 25431866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutional abnormalities of chromosome 21 predispose to iAMP21-acute lymphoblastic leukaemia.
    Harrison CJ; Schwab C
    Eur J Med Genet; 2016 Mar; 59(3):162-5. PubMed ID: 26836400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
    Sinclair PB; Blair HH; Ryan SL; Buechler L; Cheng J; Clayton J; Hanna R; Hollern S; Hawking Z; Bashton M; Schwab CJ; Jones L; Russell LJ; Marr H; Carey P; Halsey C; Heidenreich O; Moorman AV; Harrison CJ
    Haematologica; 2018 Apr; 103(4):634-644. PubMed ID: 29449437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH2B3 inactivation through CN-LOH 12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain.
    Sinclair PB; Ryan S; Bashton M; Hollern S; Hanna R; Case M; Schwalbe EC; Schwab CJ; Cranston RE; Young BD; Irving JAE; Vora AJ; Moorman AV; Harrison CJ
    Leukemia; 2019 Aug; 33(8):1881-1894. PubMed ID: 30816328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and Clinical Characteristics of Intrachromosomal Amplification of Chromosome 21 in Korean Childhood B-lineage Acute Lymphoblastic Leukemia.
    Kim J; Lyu CJ; Shin S; Lee ST; Choi JR
    Ann Lab Med; 2016 Sep; 36(5):475-80. PubMed ID: 27374714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of chromatin remodeling and tyrosine kinase genes in iAMP21-positive acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Zachariadis V; Taylan F; Marincevic-Zuniga Y; Tran AN; Saft L; Nilsson D; Syvänen AC; Lönnerholm G; Harila-Saari A; Nordenskjöld M; Heyman M; Nordgren A; Nordlund J; Barbany G
    Leuk Lymphoma; 2020 Mar; 61(3):604-613. PubMed ID: 31640433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21.
    Sharma R; Klairmont MM; Holland AC; Choi JK; Mullighan CG; Wang L; Sandlund JT; Pui CH; Inaba H
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28357. PubMed ID: 32469139
    [No Abstract]   [Full Text] [Related]  

  • 19. B-cell acute lymphoblastic leukemia with iAMP21 in a patient with Down syndrome due to a constitutional isodicentric chromosome 21.
    Verdoni AM; Zilla ML; Bullock G; Guinipero TL; Meade J; Yatsenko SA
    Am J Med Genet A; 2022 Aug; 188(8):2325-2330. PubMed ID: 35678493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
    Moorman AV; Richards SM; Robinson HM; Strefford JC; Gibson BE; Kinsey SE; Eden TO; Vora AJ; Mitchell CD; Harrison CJ;
    Blood; 2007 Mar; 109(6):2327-30. PubMed ID: 17095619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.